CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...